SPY331.77+1.71 0.52%
DIA271.27+2.86 1.07%
IXIC10,979.32+38.16 0.35%

Raymond James Initiates Coverage On VBI Vaccines with Outperform Rating, Announces $3 Price Target

Raymond James initiates coverage on VBI Vaccines (NASDAQ:VBIV) with a Outperform rating and a $3 price target.

Benzinga · -

Raymond James initiates coverage on VBI Vaccines (NASDAQ:VBIV) with a Outperform rating and a $3 price target.